PH27143A - Process for separation and centration of apolipoproteins - Google Patents
Process for separation and centration of apolipoproteins Download PDFInfo
- Publication number
- PH27143A PH27143A PH39669A PH39669A PH27143A PH 27143 A PH27143 A PH 27143A PH 39669 A PH39669 A PH 39669A PH 39669 A PH39669 A PH 39669A PH 27143 A PH27143 A PH 27143A
- Authority
- PH
- Philippines
- Prior art keywords
- emulsion
- blood
- perfluorocarbon
- protein
- phospholipid
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 26
- 108010071619 Apolipoproteins Proteins 0.000 title description 12
- 102000007592 Apolipoproteins Human genes 0.000 title description 12
- 238000000926 separation method Methods 0.000 title description 8
- 239000000839 emulsion Substances 0.000 claims description 46
- 239000008280 blood Substances 0.000 claims description 29
- 210000004369 blood Anatomy 0.000 claims description 29
- TXEYQDLBPFQVAA-UHFFFAOYSA-N tetrafluoromethane Chemical compound FC(F)(F)F TXEYQDLBPFQVAA-UHFFFAOYSA-N 0.000 claims description 29
- 102000004169 proteins and genes Human genes 0.000 claims description 22
- 108090000623 proteins and genes Proteins 0.000 claims description 22
- 239000002245 particle Substances 0.000 claims description 15
- 102000004895 Lipoproteins Human genes 0.000 claims description 11
- 108090001030 Lipoproteins Proteins 0.000 claims description 11
- 150000003904 phospholipids Chemical class 0.000 claims description 10
- 239000000243 solution Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 229910052731 fluorine Inorganic materials 0.000 claims description 3
- 239000011737 fluorine Substances 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 2
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 claims 2
- 239000004215 Carbon black (E152) Substances 0.000 claims 2
- 229930195733 hydrocarbon Natural products 0.000 claims 2
- 150000002430 hydrocarbons Chemical class 0.000 claims 2
- 239000002736 nonionic surfactant Substances 0.000 claims 2
- 240000008570 Digitaria exilis Species 0.000 claims 1
- 235000019715 Fonio Nutrition 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 239000000499 gel Substances 0.000 description 18
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 14
- 150000001875 compounds Chemical class 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- 239000008346 aqueous phase Substances 0.000 description 7
- 229940107161 cholesterol Drugs 0.000 description 7
- 239000003599 detergent Substances 0.000 description 7
- 235000012000 cholesterol Nutrition 0.000 description 6
- 239000008344 egg yolk phospholipid Substances 0.000 description 6
- 229940068998 egg yolk phospholipid Drugs 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- 239000000872 buffer Substances 0.000 description 5
- -1 perfluoro Chemical class 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Inorganic materials [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 241000700159 Rattus Species 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 4
- BKIMMITUMNQMOS-UHFFFAOYSA-N nonane Chemical compound CCCCCCCCC BKIMMITUMNQMOS-UHFFFAOYSA-N 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 108010046315 IDL Lipoproteins Proteins 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 108010062497 VLDL Lipoproteins Proteins 0.000 description 2
- ORILYTVJVMAKLC-UHFFFAOYSA-N adamantane Chemical compound C1C(C2)CC3CC1CC2C3 ORILYTVJVMAKLC-UHFFFAOYSA-N 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- NNBZCPXTIHJBJL-UHFFFAOYSA-N decalin Chemical compound C1CCCC2CCCCC21 NNBZCPXTIHJBJL-UHFFFAOYSA-N 0.000 description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- YNPNZTXNASCQKK-UHFFFAOYSA-N phenanthrene Chemical compound C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 2
- XOKSLPVRUOBDEW-UHFFFAOYSA-N pinane Chemical compound CC1CCC2C(C)(C)C1C2 XOKSLPVRUOBDEW-UHFFFAOYSA-N 0.000 description 2
- 230000001603 reducing effect Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- RSJKGSCJYJTIGS-UHFFFAOYSA-N undecane Chemical compound CCCCCCCCCCC RSJKGSCJYJTIGS-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- GNMCGMFNBARSIY-UHFFFAOYSA-N 1,2,3,4,4a,4b,5,6,7,8,8a,9,10,10a-tetradecahydrophenanthrene Chemical compound C1CCCC2C3CCCCC3CCC21 GNMCGMFNBARSIY-UHFFFAOYSA-N 0.000 description 1
- LDMOEFOXLIZJOW-UHFFFAOYSA-N 1-dodecanesulfonic acid Chemical compound CCCCCCCCCCCCS(O)(=O)=O LDMOEFOXLIZJOW-UHFFFAOYSA-N 0.000 description 1
- LXTHCCWEYOKFSR-UHFFFAOYSA-N 1-ethyladamantane Chemical compound C1C(C2)CC3CC2CC1(CC)C3 LXTHCCWEYOKFSR-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 102000005666 Apolipoprotein A-I Human genes 0.000 description 1
- 108010059886 Apolipoprotein A-I Proteins 0.000 description 1
- 102000006991 Apolipoprotein B-100 Human genes 0.000 description 1
- 108010008150 Apolipoprotein B-100 Proteins 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 101100536354 Drosophila melanogaster tant gene Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 101100345589 Mus musculus Mical1 gene Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 239000003633 blood substitute Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000009260 cross reactivity Effects 0.000 description 1
- 150000001923 cyclic compounds Chemical class 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 125000004855 decalinyl group Chemical group C1(CCCC2CCCCC12)* 0.000 description 1
- 238000002298 density-gradient ultracentrifugation Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 102000019758 lipid binding proteins Human genes 0.000 description 1
- 108091016323 lipid binding proteins Proteins 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 150000002790 naphthalenes Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- WKHMXCIUCCIPOU-UHFFFAOYSA-N perfluoro-1-methyladamantane Chemical compound FC1(F)C(C2(F)F)(F)C(F)(F)C3(F)C(F)(F)C2(F)C(F)(F)C1(C(F)(F)F)C3(F)F WKHMXCIUCCIPOU-UHFFFAOYSA-N 0.000 description 1
- YVBBRRALBYAZBM-UHFFFAOYSA-N perfluorooctane Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F YVBBRRALBYAZBM-UHFFFAOYSA-N 0.000 description 1
- RVZRBWKZFJCCIB-UHFFFAOYSA-N perfluorotributylamine Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)N(C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F RVZRBWKZFJCCIB-UHFFFAOYSA-N 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 229930006728 pinane Natural products 0.000 description 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000005199 ultracentrifugation Methods 0.000 description 1
- PXXNTAGJWPJAGM-UHFFFAOYSA-N vertaline Natural products C1C2C=3C=C(OC)C(OC)=CC=3OC(C=C3)=CC=C3CCC(=O)OC1CC1N2CCCC1 PXXNTAGJWPJAGM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28556688A | 1988-12-16 | 1988-12-16 | |
US33440889A | 1989-04-07 | 1989-04-07 | |
US07/420,097 US4975528A (en) | 1989-04-07 | 1989-10-16 | Process for separation and concentration of apolipoproteins using perfluorocarbon emulsion |
Publications (1)
Publication Number | Publication Date |
---|---|
PH27143A true PH27143A (en) | 1993-04-02 |
Family
ID=27403537
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH39669A PH27143A (en) | 1988-12-16 | 1989-12-11 | Process for separation and centration of apolipoproteins |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0373916A3 (da) |
JP (1) | JPH02212500A (da) |
AU (1) | AU4675289A (da) |
CA (1) | CA2004830A1 (da) |
DK (1) | DK614689A (da) |
ES (1) | ES2019017A6 (da) |
FI (1) | FI895980A0 (da) |
GR (1) | GR1000501B (da) |
IL (1) | IL92584A (da) |
MX (1) | MX170987B (da) |
NO (1) | NO895077L (da) |
PH (1) | PH27143A (da) |
PT (1) | PT92568B (da) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5672685A (en) * | 1995-10-04 | 1997-09-30 | Duke University | Source of apolipoprotein E and method of isolating apolipoprotein E |
-
1989
- 1989-12-06 DK DK614689A patent/DK614689A/da not_active Application Discontinuation
- 1989-12-07 CA CA002004830A patent/CA2004830A1/en not_active Abandoned
- 1989-12-07 IL IL92584A patent/IL92584A/xx active IP Right Grant
- 1989-12-11 PH PH39669A patent/PH27143A/en unknown
- 1989-12-13 EP EP19890313040 patent/EP0373916A3/en not_active Withdrawn
- 1989-12-14 PT PT92568A patent/PT92568B/pt not_active IP Right Cessation
- 1989-12-14 AU AU46752/89A patent/AU4675289A/en not_active Abandoned
- 1989-12-14 FI FI895980A patent/FI895980A0/fi not_active Application Discontinuation
- 1989-12-15 NO NO89895077A patent/NO895077L/no unknown
- 1989-12-15 MX MX018749A patent/MX170987B/es unknown
- 1989-12-15 ES ES9000103A patent/ES2019017A6/es not_active Expired - Lifetime
- 1989-12-15 JP JP1324195A patent/JPH02212500A/ja active Pending
- 1989-12-18 GR GR890100828A patent/GR1000501B/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK614689D0 (da) | 1989-12-06 |
MX170987B (es) | 1993-09-22 |
FI895980A0 (fi) | 1989-12-14 |
PT92568A (pt) | 1990-06-29 |
GR1000501B (el) | 1992-07-30 |
JPH02212500A (ja) | 1990-08-23 |
IL92584A (en) | 1997-03-18 |
EP0373916A3 (en) | 1991-05-08 |
DK614689A (da) | 1990-06-17 |
PT92568B (pt) | 1995-08-09 |
AU4675289A (en) | 1990-06-21 |
GR890100828A (en) | 1991-03-15 |
IL92584A0 (en) | 1990-08-31 |
EP0373916A2 (en) | 1990-06-20 |
NO895077D0 (no) | 1989-12-15 |
ES2019017A6 (es) | 1991-05-16 |
CA2004830A1 (en) | 1990-06-16 |
NO895077L (no) | 1990-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Biesecker et al. | C5b-9 dimer: isolation from complement lysed cells and ultrastructural identification with complement-dependent membrane lesions. | |
Allen et al. | Detergent removal during membrane reconstitution | |
Viitanen et al. | [32] Purification, reconstitution, and characterization of the lac permease of Escherichia coli | |
Blumenthal et al. | Dilation of the influenza hemagglutinin fusion pore revealed by the kinetics of individual cell-cell fusion events. | |
Ellena et al. | Lipid-protein interactions in reconstituted membranes containing acetylcholine receptor | |
Cladera et al. | Liposome solubilization and membrane protein reconstitution using Chaps and Chapso | |
Damen et al. | Transfer and exchange of phospholipid between small unilamellar liposomes and rat plasma high density lipoproteins Dependence on cholesterol content and phospholipid composition | |
Conrad et al. | Evidence for a large internal pressure in biological membranes. | |
Doolittle et al. | Solubilization, partial purification, and reconstitution in phosphatidylcholine-cholesterol liposomes of acyl-CoA: cholesterol acyltransferase | |
JPS58183625A (ja) | 酸素運搬システム | |
Hvatum et al. | Studies on tissue thromboplastin-its splitting into two separable parts | |
Kagawa | Dissociation and reassembly of the inner mitochondrial membrane | |
Lenaz et al. | Lipid-protein interactions in mitochondria: I. Conditions affecting binding of phospholipids to lipid-depleted mitochondria | |
Gerritsen et al. | The transbilayer movement of phosphatidylcholine in vesicles reconstituted with intrinsic proteins from the human erythrocyte membrane | |
Lelkes et al. | Studies on the methodology of the carboxyfluorescein assay and on the mechanism of liposome stabilization by red blood cells in vitro | |
Abeywardena et al. | Lipid-protein interactions of reconstituted membrane-associated adenosinetriphosphatases. Use of a gel-filtration procedure to examine phospholipid-activity relationships | |
US4975528A (en) | Process for separation and concentration of apolipoproteins using perfluorocarbon emulsion | |
PH27143A (en) | Process for separation and centration of apolipoproteins | |
Hallberg et al. | Lipoprotein fractionation in deuterium oxide gradients: a procedure for evaluation of antioxidant binding and susceptibility to oxidation. | |
Prendergast et al. | Lipid order-disorder transitions in complexes of melittin and ditetra-and dipentadecanoylglycerophosphocholines | |
Podlecki et al. | Characterization of the receptor binding properties of monoiodoinsulin isomers and the identification of different insulin receptor specificities in hepatic and extrahepatic tissues | |
LOPEZ‐CORCUERA et al. | Solubilization and reconstitution of the sodium‐and‐chloride‐coupled glycine transporter from rat spinal cord | |
Walter | Cell partitioning in two-polymer aqueous phase systems | |
Sawada et al. | Sodium dodecyl sulfate-disc gel electrophoresis patterns of bovine lung surfactant | |
Shaw et al. | Proton nuclear magnetic resonance study of the decay of transbilayer compositional asymmetry generated by a phosphatidylcholine exchange protein |